Changeflow GovPing Healthcare & Life Sciences Trapeziometacarpal Joint Arthroplasty Versus Tr...
Routine Notice Added Final

Trapeziometacarpal Joint Arthroplasty Versus Trapeziectomy for Thumb Carpometacarpal Osteoarthritis RCT

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

Sahlgrenska University Hospital in Gothenburg, Sweden has registered a single-centre, blinded randomized controlled trial comparing trapeziometacarpal prosthetic arthroplasty versus trapeziectomy for symptomatic thumb carpometacarpal osteoarthritis in adults aged 18-69 years with Eaton grade 2-3 disease refractory to 3 months of non-operative treatment. The target enrollment is 64 participants randomized 1:1, with primary outcome of day-by-day pain measured on a numeric rating scale (NRS 0-10) and follow-up extending to 10 years.

“The target sample size is 64 participants (32 per group), providing 95% power to detect a 1-point between-group difference on the pain scale.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

What changed

A randomized controlled trial registration was added to ClinicalTrials.gov for a single-centre study at Sahlgrenska University Hospital, Gothenburg, Sweden. The trial will enroll 64 adults aged 18-69 with symptomatic thumb carpometacarpal osteoarthritis (Eaton grade 2-3) refractory to at least 3 months of non-operative treatment, randomized 1:1 to either trapeziometacarpal prosthetic arthroplasty or trapeziectomy.

This trial registration provides notice of an upcoming clinical investigation comparing two surgical approaches for thumb arthritis. The 10-year follow-up period and comprehensive outcome measures including pain, function, and imaging make this a long-term comparative effectiveness study. No compliance obligations are created by this registration.

Archived snapshot

Apr 28, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Trapeziometacarpal Joint Arthroplasty Versus Trapeziectomy for Thumb Carpometacarpal Osteoarthritis

N/A NCT07552831 Kind: NA Apr 27, 2026

Abstract

Thumb carpometacarpal osteoarthritis is common and may cause severe pain and functional limitation. Trapeziectomy is widely used, whereas prosthetic arthroplasty may offer faster early recovery. However, detailed information on early postoperative and long-term radiological outcomes remains limited.

This is a single-centre, blinded randomised controlled trial at Sahlgrenska University Hospital, Gothenburg, Sweden. Adults aged 18-69 years with symptomatic thumb carpometacarpal osteoarthritis (Eaton grade 2-3) refractory to at least 3 months of non-operative treatment will be randomised 1:1 to trapeziometacarpal prosthetic arthroplasty or trapeziectomy. The primary outcome is day-by-day pain (registration on a numeric rating scale NRS, 0-10). Secondary outcomes include day-by-day analgesic consumption for 90 days, orthosis use after cast removal, patient-reported function (HQ-8, QuickDASH, and Nelson score) at 30, 45, 60, 75 and 90 days, assessor-measured range of motion and strength at 45 and 90 days, and long-term clinical follow-up at 6 months and 1, 2, 5 and 10 years. Cone beam computed tomography will be obtained in the arthroplasty group at 1 week postoperatively as reference and at 6 months and 1, 2, 5 and 10 years to assess implant position, migration and loosening. The target sample size is 64 participants (32 per group), providing 95% power to detect a 1-point between-group difference on the pain scale. Analyses will follow the intention-to-treat principle.

Conditions: Thumb Osteoarthritis

Interventions: trapeziometacarpal arthroplasty, Trapeziectomy

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Surgical research Medical device evaluation
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Medical Devices Pharmaceuticals

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!